Synta Pharmaceuticals Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Synta Pharmaceuticals

SNTA 0.343

+26.6%

Jul 22 5:00 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 PreviousNext

To: Steve Lokness who wrote (111)	9/4/2012 9:55:24 PM
From: mcbio	of 112

Yes, quite a day. Up 15% on no news and 2x normal volume. Sasha Damouni (Bloomberg) speculated on Twitter that the rise was due to the fact that the lung cancer data at ESMO (conference at end of this month) will be presented to the press and so it must be interesting. Feuerstein speculated that the rise could be due to data contained in the ESMO media program that may have been released. I have no idea if either of those explanations are the reason for the big jump. I do know I haven't sold any shares and will continue to hold until we get more mature ganetespib data, for better or worse.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 PreviousNext